Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rankning i aktier #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Aktiekurs
$0.25974701
Senast synkroniserad: 2025-01-06
Marknadsvärde
$2.04M
Förändring (1 dag)
0.74%
Förändring (1 år)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategori

Healthcare
Antal utestående aktier för Acticor Biotech SAS (ALACT)
Antal utestående aktier per June 2024: 15.76M
Enligt de senaste finansiella rapporterna och aktiekursen för Acticor Biotech SAS är det aktuella antalet utestående aktier 15.76M. I slutet av December 2022 hade företaget 10.55M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Acticor Biotech SAS (ALACT) från 2010 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 15.76M 30.55%
2023 12.07M 14.44%
2022 10.55M 35.54%
2021 7.78M 22.37%
2020 6.36M 21.38%
2019 5.24M 70.67%
2018 3.07M -7.38%
2017 3.31M 0.00%
2016 3.31M 0.00%
2015 3.31M 0.00%
2014 3.31M 0.00%
2013 3.31M 0.71%
2012 3.29M 0.00%
2011 3.29M -34.01%
2010 4.99M 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 1,511.53%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 294.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 2,939.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 2,413.45%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH